Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Gains from Investment Securities (2020 - 2025)

Alignment Healthcare posted quarterly Gains from Investment Securities of $72000.0 for Q4 2025, up 7100.0% year-on-year from $1000.0 in Q4 2024, and up 7100.0% on a QoQ basis from $1000.0 in Q4 2024.

Alignment Healthcare (ALHC) has 4 years of Gains from Investment Securities data on file, last reported at $72000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 7100.0% year-over-year to $72000.0; the trailing twelve-month figure through Dec 2025 stood at $72000.0 (up 700.0% YoY), and the FY2025 full-year result was $72000.0, up 700.0% from the prior year.
  • Gains from Investment Securities for Q4 2025 stood at $72000.0, up from $1000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $10.3 million in Q3 2023 and bottomed at -$342000.0 in Q3 2024.
  • The 3-year median for Gains from Investment Securities is $44797.5 (2023), against an average of $1.7 million.
  • The widest annual swing landed in 2024, when Gains from Investment Securities sank 103.33%; it then jumped 7100.0% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $10.3 million in 2023, then sank by 99.99% to $1000.0 in 2024, then surged by 7100.0% to $72000.0 in 2025.
  • The last three Gains from Investment Securities figures came in at $72000.0 (Q4 2025), $1000.0 (Q4 2024), and -$342000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Unitedhealth 345.31 Bn 315.51 Bn 98.90 Bn
2 Cvs Health 115.41 Bn 103.79 Bn 4.43 Bn
3 Elevance Health 88.60 Bn 53.18 Bn 13.88 Bn
4 Cigna 72.05 Bn 64.43 Bn -44.29 Bn
5 Humana 39.05 Bn 17.15 Bn 4.00 Bn
6 Centene 30.50 Bn 6.84 Bn 49.24 Bn
7 Molina Healthcare 9.31 Bn 60.65 Mn 1.53 Bn
8 Oscar Health 6.86 Bn 63.05 Mn -3.22 Bn
9 Alignment Healthcare 2.69 Bn 1.96 Bn 135.85 Mn
10 Progyny 2.12 Bn 1.90 Bn 83.07 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 72,000.00
Dec 31, 2025 72,000.00
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 -342,000.00
Sep 30, 2024 -342,000.00
Mar 31, 2024 350,000.00
Mar 31, 2024 350,000.00
Sep 30, 2023 10.27 Mn
Sep 30, 2023 10.27 Mn
Jun 30, 2023 17,595.00
Jun 30, 2023 17,595.00
Dec 31, 2020 -16,000.00
Dec 31, 2020 -16,000.00
Jun 30, 2020 -130,000.00
Jun 30, 2020 -130,000.00
Mar 31, 2020 -860,000.00
Mar 31, 2020 -860,000.00